相关实验视频

Updated: May 29, 2025

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

抗体药物联合体 (ADCs):塑造精密瘤学的未来

Irene Sevilla-Carrillo¹, Eloína García-Tercero¹, Carlos Alonso-Moreno¹

¹Departamento de Química Inorgánica, Orgánica y Bioquímica, Facultad de Farmacia-Centro de Innovación en Química Avanzada (ORFEO-CINQA), Universidad de Castilla-La Mancha, Unidad nanoDrug, Albacete, 02071, Spain.

Anti-cancer agents in medicinal chemistry

|February 4, 2025

概括

抗体-药物合物 (ADC) 代表了癌症治疗的重大进步,将抗体与强效药物联系起来以进行向治疗. 目前正在进行的研究旨在优化ADC设计,以提高疗效和减少副作用.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
生物技术是生物技术.

背景情况:

抗体-药物合物 (ADC) 将单克隆抗体与细胞毒药物集成为向癌症治疗.
ADCs利用抗体特异性直接向癌细胞输送强效药物,最大限度地降低全身毒性.

研究的目的:

提供当前抗体-药物联合体 (ADC) 技术的全面审查.
讨论FDA批准的ADC,正在进行的临床试验,以及ADC开发中的新兴创新.
突出未来的研究方向,以优化ADC的有效性和安全性.

主要方法:

对抗体-药物合物 (ADC) 组件,机制和临床应用的文献综述.
对当前FDA批准的ADC和临床开发中的药物的分析.
探索新的ADC策略,包括双特异性抗体和亲药物合物.

主要成果:

抗癌药物已经成为瘤学中重要的治疗类.
目前的ADC技术包括已批准的药物和临床试验中的众多候选药物.
诸如双特异性抗体和亲药联体之类的创新显示出增强向性和降低毒性的前景.

结论:

进一步的研究对于完善抗体药物联合体 (ADC) 设计和最大限度地提高治疗潜力至关重要.
优化ADC策略可以改善癌症治疗结果.
在ADC开发中持续创新对于克服向癌症治疗方面的挑战至关重要.

关键词:

这些ADC是ADCs.美国食品和药物管理局批准的药物.抗体是一种抗体.临床试验中的临床试验.它们的作用机制.瘤学在瘤学方面.

更多相关视频

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Targeted Antibody Blocking by a Dual-Functional Conjugate of Antigenic Peptide and Fc-III Mimetics DCAF

Published on: September 17, 2019

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Antibody Actions

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Antibody Structure

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...